Immunological Studies on Experimental Infection of Pigs with Ascaris suum Goeze, 1782. V.—The Antibody Response to the Oral Administration of Third- and Fourth-Stage Larvae

1964 ◽  
Vol 38 (1-2) ◽  
pp. 159-170 ◽  
Author(s):  
L. F. Taffs

Following the oral administration of third- and fourth-stage A. suum larvae, which had previously completed nine or ten days somatic migration in guineapigs, rabbits or a pig, six out of eight pigs showed a rise of serum antibody titre, as measured by the conglutinating complement absorption test using a saline extract of Ascaris worm as antigen. Four of these pigs had negative titres before infection, and in these animals antibodies were first detected between the 14th and 20th days. Maximum serum antibody concentration was reached between the 14th and 34th days of infection, and antibodies were detected for at least as long as 68 days.Larvae were recovered from the faeces on the 23rd and 29th days of infection, and in two pigs out of eight the larvae reached maturity, eggs first being seen in the faeces on the 42nd day.The results suggest that (1) Ascaris larvae, on their return to the intestine, release antigenic substances which are then absorbed by the gut wall to stimulate the production of antibodies; (2) the secondary antibody rise, which occurs about the sixth or seventh week of an infection with Ascaris eggs, is due to the absorption of this larval antigen; and (3) the moulting process (fourth moult) is not only an important stage for stimulating this further antibody production, but is also the time when maturing larvae are affected by the immune mechanisms of the host.On reinfection with Ascaris eggs the phenomenon of “self-cure” was noticed. A fall in the faecal egg count, which became negative on the 21st day, was accompanied by a sharp rise in antibody titre. An increase in the number of infertile eggs in the faeces, rising from 11% on the day of reinfection to 100% on the 14th day, was also observed.

1947 ◽  
Vol 45 (4) ◽  
pp. 497-503 ◽  
Author(s):  
N. H. Hole ◽  
R. R. A. Coombs

1. Observations on the sera of ponies, taken at frequent intervals for 321 days after oral administration of P. mallei, are described.2. It was found that the conglutinating complement absorption test was more sensitive than the haemolytic complement fixation test as a means of diagnosis. It detected the antibodies earlier in the course of the disease and demonstrated their presence over a longer period of time.3. The possibility of another practical use of this reaction as an adjunct to the allergic test is considered. Ten days after an intradermo-palpebral test a pony, which had been previously sensitized and whose serum antibody titre at that time was below 10, developed a serum titre of over 160 as demonstrated by the conglutinating complement absorption test. Under similar circumstances 11 unsensitized ponies developed no detectable serum antibodies.


1983 ◽  
Vol 90 (1) ◽  
pp. 107-115 ◽  
Author(s):  
A. Goodeve ◽  
C. W. Potter ◽  
A. Clark ◽  
R. Jennings ◽  
G. C. Schild ◽  
...  

SUMMARYOne hundred and nineteen volunteers were divided into five groups, and each volunteer inoculated subcutaneously with an aqueous subunit B/Hong Kong/73 vaccine containing 40, 20, 10, or 5 μg of HA or saline alone in a 0·5 ml volume. The incidence of reactions was recorded 24 h after inoculation. One month following immunization the serum HI antibody to B/Hong Kong/73 virus was measured; each volunteer was inoculated intranasally with live, attenuated influenza B (RB77) virus; and the incidence of infection by the challenge virus was determined by HI antibody response.The results showed that the incidence of reactions to all doses of vaccine were relatively low, the severity mild, and the duration short. However, the incidence of reactions was highest for those given 40 μg HA and least for those given 5 μg HA. The serum HI antibody responses to vaccine showed a dose-response relationship. For volunteers given 40 μg HA, 22 (96%) showed a fourfold rise in antibody titre and all volunteers had antibody titres of > 40 following immunization: for volunteers given 5 μg HA the g.m.t. increased from 16·6 to 86·1; and for those given 10 and 20 μg HA the response was intermediate. Following challenge, the lowest incidence of infection was seen in volunteers given the highest dose of vaccine. However, all doses of vaccine induced some protection against challenge virus infection, and the incidence of infection was directly related to the serum antibody titre at the time of challenge. The 50% protection titre of serum HI antibody was estimated as 15 to 20.


1995 ◽  
Vol 4 (6) ◽  
pp. 372-376 ◽  
Author(s):  
Hendri H. Pas ◽  
Marcelus C. J. M. Jong ◽  
Marcel E Jonkman ◽  
Klaas Heeres ◽  
Ida J. Slijper-Pal ◽  
...  

1979 ◽  
Vol 13 (2) ◽  
pp. 143-148 ◽  
Author(s):  
A. Schaich Fries

Summary The correlation between serum antibody titre and resistance to challenge infection with Bacillus piliformis was studied in naturally infected mice, in experimentally infected but recovered mice, and in mice treated with antigen prepared from infected livers. Irrespective of the way in which the antibodies were acquired resistance to infection was found to be related to the immunofluorescence antibody titre found. Experimentally infected but recovered mice, as well as rats with persistent antibodies to Bacillus piliformis, were given prednisolone in order to activate a possible persistent infection. Bacillus piliformis was detected in the rats, but not in the mice.


1992 ◽  
Vol 11 (1) ◽  
pp. 11-16 ◽  
Author(s):  
L. Institóris ◽  
Olga Siroki ◽  
S. Tóth ◽  
I. Dési

The effects of a single large and repeated small doses of MPT-IP (the industrial product used to produce Wofatox EC 50) containing 60% methylparathion, on the humoral and cellular immunoreactivity of CFLP mice were investigated. Administration of a single LD50/2 dose 3 d prior to immunization caused a 40% increase in the number of splenic PFC on the 5th day but no significant increase in serum antibody titre on the 7th day after immunization. Treatment for 4 weeks with an LD50/40 dose resulted in a 100% increase in splenic PFC, also not associated with a change in serum antibody titre. Under the same conditions and LD50/20 dose had no effect on these parameters. Neither the single large nor the repeated small doses had any effect on the intensity or time course of a DTH reaction. The results show that MPT-IP has an immunotoxic potential in mice under certain experimental conditions.


Nutrients ◽  
2021 ◽  
Vol 13 (3) ◽  
pp. 813
Author(s):  
Cynthia B. Van Van Landingham ◽  
Debra R. Keast ◽  
Matthew P. Longnecker

Treatment with prebiotics, a type of dietary fiber, was recently shown to increase antibody concentrations following influenza vaccination in a meta-analysis of clinical trials. In observational epidemiologic studies it is not possible to estimate intake of prebiotics, but quantifying intake of dietary fiber is routine. Our objective was to investigate the potential effect of dietary fiber on immunogenicity. We examined serum antibody concentrations (Measles, Mumps, Rubella, and Varicella) in relation to dietary fiber in more than 12,000 subjects in the U.S. National Health and Nutrition Examination Survey (NHANES) for the period 1999–2004. Data from one (1999–2002) or two (2003–2004) dietary recalls were used to calculate fiber intake. For Mumps the adjusted percentage difference in antibody concentration per interquartile range intake in energy-adjusted dietary fiber was 6.34% (95% confidence interval, 3.10, 9.68). Fiber from grain-based foods was more positively associated than fiber from other fiber-containing food groups. The association was slightly larger among subgroups with higher fiber intake, greater interquartile range in fiber intake, and less measurement error. Furthermore, based on the reliability of the diet recalls in 2003–2004, we calculated that the percentage difference per interquartile increment was substantially attenuated by measurement error. Dietary fiber may have a favorable influence on the immunogenicity of some vaccines or natural infections.


PEDIATRICS ◽  
1998 ◽  
Vol 102 (Supplement_1) ◽  
pp. 252-254
Author(s):  
Georges Peter

One hundred forty-one children of 5 to 59 months of age were immunized with a single intramuscular dose of 0.67, 3.3, 17, or 67 μg polyribophosphate (PRP), the capsular antigen ofHemophilus influenzae, type b. The immunizations were well tolerated, particularly at doses of .67 to 17 μg. Antibody activity was measured by radioactive antigen binding, using3H-labelled PRP. Doses of 3.3 and 17 μg produced significant antibody rises in nearly 90% of recipients; 0.67 and 67 μg in approximately half. The geometric mean titers were similar at three and six weeks after immunization and were greater with the middle doses. The net antibody increase in responding children was strongly age dependent, but was not related to the preimmunization antibody concentration. Rises in serum bactericidal activity against H. influenzae type b generally accompanied rises in antibody concentration as measured by the antigen-binding assay. A recently developed Haemophilus influenzae type b capsular polysaccharide vaccine was given to 48 977 children 3 months to 5 years of age; an equal number of children receiving group A meningococcal vaccine served as controls. The protection as well as serum antibody response was strongly age dependent. Among children who had received the H. influenzae type b vaccine when 18 months of age or older, there were no cases of bacteremic disease caused by H. influenzaetype b in the first year after vaccination. At the same time 11 such cases were seen in the control group of the same age, a highly significant difference. In the second year after vaccination two cases occurred in the H. influenzae type b-vaccinated group, five in the meningococcal-group A vaccinated group. No protection was seen among children who had been younger than 18 months when vaccinated, even if they received a booster dose of the vaccine. The serum antibody response to the H. influenzae type b polysaccharide, measured by radioimmunoassay, was poor in children below 18 months of age and good in those above it. No effect of the vaccine could be seen on the nasopharyngeal carriage of H. influenzae type b, which was approximately 6% in this age group. Adverse effects of the vaccine were mild.


PEDIATRICS ◽  
1987 ◽  
Vol 80 (2) ◽  
pp. 283-287
Author(s):  
Allen A. Lenoir ◽  
Paul D. Granoff ◽  
Dan M. Granoff

Fifty infants, 2 to 6 months of age, were vaccinated with Haemophilus influenzae type b capsular polysaccharide covalently linked to an outer membrane protein from Neisseria meningitidis group B. Subjects were given two injections and were randomly assigned to receive the injections separated by 1 or 2 months. Each dose contained 15 µg of polysaccharide and 51 µg of protein, or approximately twice the amount of polysaccharide as used in our previous trial (Lancet 1986;2:299). Fevers of 38.0° to 38.8°C developed in three infants (6%) within 24 hours after vaccination, but there were no other notable reactions. Following one injection, the geometric mean antibody concentration increased from 0.13 µg/mL in preimmune serum to 1.50 µg/mL in serum obtained 1 to 2 months later (P < .001). After a second injection, there was a further increase in serum antibody (geometric mean = 3.11 µg/mL, P < .007). The geometric mean antibody concentration of the group reimmunized 2 months after the first injection was higher than that in the group reimmunized after 1 month (3.95 v 2.32 µg/mL, P = .05, by analysis of covariance with age as the covariant). These data confirm our previous preliminary observations on the safety and immunogenicity of this new conjugate vaccine in infants 2 to 6 months of age. The data suggest that a 2-month interval between the first and second injections results in higher levels of serum antibody than a 1-month interval.


Sign in / Sign up

Export Citation Format

Share Document